a.salcedo
TL3 Regular · Canberra, AU
Wiki editor. Small, frequent, well-annotated edits.
Joined 1 November 2024 · last posted 13h · groups: wiki-editors
141 posts, newest first. Showing up to 150.
-
Shoulders, tangent skims, and defensible integration Replied, post #21 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 1 like Where the baseline is drawn is the least documented and most consequential choice in the whole determination. Valley-to-valley, tangent skim and forced-to-zero can span…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #109 · Start Here › Welcome · 25 Jul 2026 · 27 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Immortal time bias in a claims-database study — one year on Replied, post #42 · Evidence › Study critique · 24 Jul 2026 · 2 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #29 · Evidence › Preprints · 20 Jul 2026 · 14 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one. If…
-
Submitting a sample: the process end to end Replied, post #95 · Sourcing › Independent verification · 19 Jul 2026 · 8 likes Adding the boring version of submitting a sample, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Documenting a supplier's response to a discrepancy Replied, post #41 · Sourcing › Vendor reports · 17 Jul 2026 · 1 like Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence. I have deliberately not rounded that, because the…
-
What a certificate commits its issuer to Replied, post #39 · Analytics › COA interpretation · 16 Jul 2026 · 0 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #62 · Practice › Dosing & titration · 13 Jul 2026 · 4 likes On post #60 — agreed on the reasoning, with one qualification. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Prescription portability between countries Replied, post #96 · Access › International · 12 Jul 2026 · 0 likes Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging. I have kept the units in…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #34 · Start Here › Welcome · 12 Jul 2026 · 6 likes Reading the guidelines before you post is genuinely worth the twenty minutes. Not because you will break one, but because the rules explain why the place reads the way…
-
Talking to a therapist about this specifically Replied, post #20 · Wellbeing › Mental health · 11 Jul 2026 · 6 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #17 · Clinical › Comorbidities · 10 Jul 2026 · 6 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #81 · Practice › Interactions · 9 Jul 2026 · 0 likes The bit of widely repeated interaction claim that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #9 · Access › Insurance & coverage · 8 Jul 2026 · 0 likes Confirming post #7 from a second method, which matters more than confirming it from a second person. Prior authorisation looks different depending on whether you are…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #75 · Evidence › Journal club · 2 Jul 2026 · 23 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
Preservatives: function, testing, and limits — one year on Replied, post #28 · Pharmacology › Formulation chemistry · 1 Jul 2026 · 6 likes Everything in post #26 holds. The case it does not cover is the one I have. Light sensitivity varies enormously between peptides depending on the residues present.…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #43 · Start Here › Welcome · 26 Jun 2026 · 4 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
CJC-1295 with and without DAC: what the modification does Replied, post #93 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 30 likes Practical answer on CJC-1295, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #77 · Compounds › Repair & healing peptides · 23 Jun 2026 · 0 likes Answering the question post #73 raises rather than the one it answers. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #32 · Compounds › Repair & healing peptides · 17 Jun 2026 · 25 likes Narrowing post #31, because the general version has more than one answer. What I would tell a new member reading about Analytical identity of BPC-157 for the first…
-
Asking a follow-up: new topic or new reply? Replied, post #9 · Start Here › How to Ask · 13 Jun 2026 · 1 like The claim about asking a follow-up upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".
-
Injecting into an area that has become firm: why not to Replied, post #58 · Practice › Administration · 12 Jun 2026 · 0 likes Post #57 put the caveat in the right place and I want to underline it. If you have to inject at a different time of day than usual, that is a much smaller perturbation…
-
Racemisation and why it is invisible to a mass measurement Replied, post #50 · Analytics › Impurities & related substances · 11 Jun 2026 · 0 likes The related-substances total is only as informative as the method that generated it. Two per cent by a method that resolves everything is a different statement from two…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #60 · Practice › Storage & stability · 5 Jun 2026 · 4 likes Two sentences on reconstituted and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow. What is…
-
A site rotation scheme that is easy enough to actually follow Replied, post #79 · Practice › Administration · 3 Jun 2026 · 25 likes A note on scope: what I am saying about site rotation scheme applies to the case in the first post and I would not extend it further without checking.
-
Sleep apnoea improving and the equipment implications Replied, post #3 · Wellbeing › Sleep · 3 Jun 2026 · 17 likes Answering the question the opening post raises rather than the one it answers. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #10 · Start Here › How to Ask · 31 May 2026 · 0 likes Quantities without units are the single commonest reason a question sits unanswered. "Two and a half" is not a dose, a volume or a concentration until you say which. I…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #56 · Safety › Contraindications · 31 May 2026 · 8 likes Picking up post #54: that is the part I would want checked first. Somebody's condition being on a list does not settle the decision, and somebody's condition being…
-
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #72 · Practice › Administration · 28 May 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #90 · Compounds › Tirzepatide · 26 May 2026 · 16 likes Taking post #87 at face value and following it one step further. I would call the community position on Tirzepatide and nausea likely rather than established, and I…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #38 · Compounds › Semaglutide · 25 May 2026 · 9 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Citation sweep results: how many references did not say what was claimed Replied, post #100 · Meta › Wiki maintenance · 23 May 2026 · 13 likes Adding the measurement that post #98 says would settle it. Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #63 · Practice › Storage & stability · 22 May 2026 · 32 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #6 · Compounds › Oral incretins · 17 May 2026 · 30 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #9 · Start Here › How to Ask · 14 May 2026 · 0 likes Post the arithmetic you already did. Half the questions here are answered by someone spotting which line of your working is wrong, and that is impossible if you only…
-
Revisiting: What pooling buys you and what it destroys Replied, post #22 · Evidence › Meta-analyses · 14 May 2026 · 4 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #117 · Devices › Syringes & needles · 14 May 2026 · 6 likes Confirming post #114 from a second method, which matters more than confirming it from a second person. Reading the barrel at eye level matters more than any equipment…
-
Reading a trial's population section before its results Replied, post #11 · Evidence › Trials · 10 May 2026 · 19 likes Post #7 describes the usual case. This is about the unusual one. A trial that answers a slightly different question from the one you have is the normal situation rather…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #113 · Practice › Storage & stability · 10 May 2026 · 14 likes Where I part company with post #111, and it is a narrow parting. Where the Storing lyophilised material long term reasoning breaks down for me is the step from the…
-
Coming back to: A structured critique template this community uses Replied, post #4 · Evidence › Study critique · 30 Apr 2026 · 11 likes The most useful reply I ever got about structured critique template was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Whether an aggregate is worth publishing at all: a disputed topic — does this still hold? Replied, post #15 · Data & Tools › Datasets · 23 Apr 2026 · 5 likes Post #14 answers the question as asked. The question underneath it is different. Units in the column header, always, and the same units down the whole column. Mixed…
-
Reading U-100 graduations, with a conversion table — one year on Replied, post #8 · Devices › Syringes & needles · 9 Apr 2026 · 0 likes Narrowing post #5, because the general version has more than one answer. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #47 · Compounds › Semaglutide · 6 Apr 2026 · 23 likes Building on post #46 rather than restating it. The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents…
-
Follow-up: State-level differences that actually matter Replied, post #36 · Regional › North America · 5 Apr 2026 · 22 likes Post #32 and I disagree about the size of the effect, not about the direction. I would put moderate confidence on the mainstream reading of State-level differences and…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #22 · Meta › Announcements · 27 Mar 2026 · 2 likes Posting my Trust level 3 requirements numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted…
-
Shoulders, tangent skims, and defensible integration — the long version Replied, post #18 · Analytics › HPLC & UHPLC · 27 Mar 2026 · 0 likes The number people quote for Shoulders is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly uninformative on…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #2 · Clinical › Comorbidities · 27 Mar 2026 · 0 likes Taking the opening post at face value and following it one step further. Reading back through the Type 2 diabetes threads from last year, the same three questions come…
-
Publication bias detection and its low power — does this still hold? Replied, post #14 · Evidence › Meta-analyses · 25 Feb 2026 · 12 likes Answering the question post #10 raises rather than the one it answers. Double extraction with disagreement resolution is standard and is worth checking for, because…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #37 · Compounds › Other compounds · 25 Feb 2026 · 0 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #57 · Practice › Dosing & titration · 12 Feb 2026 · 0 likes Post #56 answers the question as asked. The question underneath it is different. Writing down the date, the dose and the site each week takes fifteen seconds and is the…
-
Trust level 3 requirements: a clarification — does this still hold? Started this topic · Meta › Announcements · 29 Jan 2026 · 46 likes Asking directly, because I could not find a straight answer: Trust level 3 requirements: a clarification — does this still hold? Two things I would like separated…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #54 · Meta › Site feedback · 26 Jan 2026 · 9 likes Topic list looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #37 · Practice › Storage & stability · 24 Jan 2026 · 1 like Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Worth reading the…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #75 · Practice › Side effects · 20 Jan 2026 · 0 likes I keep a log for muscle cramps specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled…
-
Aggregates and why a purity assay may miss them entirely Replied, post #65 · Analytics › Impurities & related substances · 11 Jan 2026 · 12 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #51 · Practice › Side effects · 8 Jan 2026 · 24 likes This follows post #50 rather than contradicting it. The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #128 · Compounds › Oral incretins · 4 Jan 2026 · 7 likes The gastrointestinal tolerability profile of the oral formulation is broadly similar in character to the injectable, which supports the effects being systemic rather…
-
Availability by country, dated, with primary sources — one year on Replied, post #12 · Access › International · 1 Jan 2026 · 0 likes Post #10 describes the usual case. This is about the unusual one. Adding the boring version of Availability, because the interesting version keeps getting posted and…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #96 · Analytics › COA interpretation · 24 Dec 2025 · 0 likes Everything in post #92 holds. The case it does not cover is the one I have. A certificate is a statement by its issuer that a defined test was performed on a defined…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #22 · Start Here › Welcome · 19 Dec 2025 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
The decimal-point error, and the habit that catches it Replied, post #102 · Practice › Reconstitution · 18 Dec 2025 · 4 likes Fair, and the limits you put on it are the part I will remember.
-
Tracking a preprint to publication: a worked example Replied, post #127 · Evidence › Preprints · 12 Dec 2025 · 2 likes Retractions and corrections do not propagate well from preprint servers. A citation that was fine when made can quietly become wrong.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #115 · Practice › Reconstitution · 8 Dec 2025 · 0 likes Careful with the language on decimal-point error. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Realistic expectations for strength while losing weight quickly Replied, post #41 · Nutrition & Training › Resistance training · 3 Dec 2025 · 10 likes On realistic expectations for strength I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
-
Pen dose counters: what a click does and does not guarantee Replied, post #71 · Devices › Pens & autoinjectors · 17 Nov 2025 · 3 likes Where I part company with post #69, and it is a narrow parting. Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the…
-
EMA product information as a primary source Replied, post #28 · Regional › European Union · 3 Nov 2025 · 0 likes Something worth flagging about EMA product information: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #73 · Analytics › HPLC & UHPLC · 30 Oct 2025 · 13 likes Where I part company with post #69, and it is a narrow parting. What I want from this detection wavelength thread is the list of things that would need to be true for…
-
Tracking that stops updating and then resumes — the long version Replied, post #31 · Sourcing › Logistics · 28 Oct 2025 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #104 · Practice › Storage & stability · 26 Oct 2025 · 24 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. Not the answer, but possibly the…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #31 · Compounds › Tirzepatide · 20 Oct 2025 · 33 likes I read post #27 twice before replying, because I had assumed the opposite. I disagree with the framing of SURMOUNT-4 above, and I think it is a substantive disagreement…
-
Coverage in the US: a map of the usual obstacles Replied, post #3 · Regional › North America · 20 Oct 2025 · 0 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.
-
Liver enzymes drifting down and what that usually means Replied, post #20 · Clinical › Bloodwork · 19 Oct 2025 · 0 likes Helpful, and short, which on this subject is harder than long.
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #55 · Start Here › Welcome · 17 Oct 2025 · 1 like This is the sort of exchange that makes the archive worth searching.
-
Reconciling a supplier certificate with an independent result Replied, post #8 · Sourcing › Vendor reports · 17 Oct 2025 · 6 likes That is the distinction I keep failing to hold on to. Written down now.
-
MHRA statements, read directly Replied, post #16 · Regional › UK & Ireland · 15 Oct 2025 · 21 likes Two claims get bundled together under MHRA statements and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
MHRA statements, read directly Replied, post #7 · Regional › UK & Ireland · 24 Sep 2025 · 0 likes Worth separating two things that post #5 runs together. Second-hand on MHRA statements, so weight it accordingly — someone whose method I trust told me this and I have…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #45 · Compounds › Repair & healing peptides · 19 Sep 2025 · 30 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Payment method and the leverage it gives you, ranked Replied, post #28 · Sourcing › Payments · 18 Sep 2025 · 14 likes Post #24 describes the usual case. This is about the unusual one. The site does not carry prices, payment details or transaction routes, and questions asking for them…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #39 · Analytics › Method validation · 9 Sep 2025 · 16 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #54 · Practice › Reconstitution · 5 Sep 2025 · 0 likes Taking post #51 at face value and following it one step further. Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #9 · Evidence › Journal club · 2 Sep 2025 · 12 likes On post #7 — agreed on the reasoning, with one qualification. Step-hfpef and symptom endpoints: I have looked for the primary source twice and failed twice. Either it…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #49 · Devices › Syringes & needles · 25 Aug 2025 · 0 likes The strongest argument against my own position on Filter needles, stated as well as I can state it, since nobody else has yet.
-
Realistic expectations for strength while losing weight quickly Replied, post #16 · Nutrition & Training › Resistance training · 25 Aug 2025 · 6 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
A payment that went through twice: how it was resolved Replied, post #2 · Sourcing › Payments · 22 Aug 2025 · 0 likes The opening post is right about the mechanism and I think understates the practical bit. The site does not carry prices, payment details or transaction routes, and…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #41 · Practice › Side effects · 19 Aug 2025 · 0 likes Post #39 describes the usual case. This is about the unusual one. A request rather than an answer: could whoever has the primary source for Fatigue post it? I have seen…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #10 · Sourcing › Regulatory · 14 Aug 2025 · 15 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #81 · Compounds › Oral incretins · 12 Aug 2025 · 16 likes Confirming post #78 from a second method, which matters more than confirming it from a second person. Fasting instructions for oral semaglutide: I would want to see the…
-
Immortal time bias in a claims-database study Replied, post #18 · Evidence › Study critique · 11 Aug 2025 · 5 likes Immortal time bias: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
Checking someone else's arithmetic: a worked example thread Replied, post #75 · Practice › Reconstitution · 7 Aug 2025 · 3 likes This is the sort of exchange that makes the archive worth searching.
-
A ten-fold dose error caught before injection — one year on Replied, post #77 · Devices › Syringes & needles · 3 Aug 2025 · 19 likes Saving this. It is the version I will quote when the question comes round again.
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #31 · Compounds › Retatrutide · 1 Aug 2025 · 15 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
How to research a compound with no human data without deceiving yourself Replied, post #11 · Compounds › Other compounds · 30 Jul 2025 · 12 likes Where I part company with post #7, and it is a narrow parting. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which…
-
Which panel is worth repeating and which is worth ignoring Replied, post #72 · Clinical › Bloodwork · 30 Jul 2025 · 23 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Correct me on the arithmetic if it is…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #58 · Access › Insurance & coverage · 27 Jul 2025 · 8 likes A well-written denial is genuinely useful because it tells you exactly what to submit next. A vague one is the harder case. I have said this before in a thread nobody…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #75 · Compounds › Repair & healing peptides · 26 Jul 2025 · 19 likes I read post #73 twice before replying, because I had assumed the opposite. Reported local reactions are common enough in first-hand accounts here to be worth mentioning…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #16 · Practice › Dosing & titration · 24 Jul 2025 · 7 likes Bookmarking this. I will come back when I have something worth adding.
-
Tracking that stops updating and then resumes Replied, post #12 · Sourcing › Logistics · 23 Jul 2025 · 21 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #6 · Compounds › Secretagogues & GH axis · 22 Jul 2025 · 25 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #34 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 5 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #134 · Devices › Cold chain · 2 Jul 2025 · 0 likes Post #133 answers the question as asked. The question underneath it is different. My experience of Domestic fridge temperature mapping contradicts the reply above. I am…
-
Repeatability versus intermediate precision Replied, post #100 · Analytics › Method validation · 30 Jun 2025 · 19 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
-
Regression to the mean in progress reports Replied, post #25 · Research Methods › Statistics · 26 Jun 2025 · 9 likes Careful with the language on regression. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #13 · Documentation › Doc review · 15 Jun 2025 · 25 likes I read post #11 twice before replying, because I had assumed the opposite. What I can speak to on Promotion criteria is narrow, so I will keep it narrow rather than…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 11 Jun 2025 · 10 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #127 · Data & Tools › Calculators · 11 Jun 2025 · 20 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
-
Pre-registering a personal experiment, seriously Replied, post #14 · Research Methods › N-of-1 designs · 26 May 2025 · 1 like On post #10 — agreed on the reasoning, with one qualification. Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1…
-
Albumin binding and how it produces a long half-life Replied, post #38 · Pharmacology › Pharmacokinetics · 20 May 2025 · 0 likes Subcutaneous absorption is the rate-limiting step for most of these compounds, which is why the apparent half-life is absorption-limited rather than…
-
Antibiotics and a course of something with delayed emptying Replied, post #43 · Practice › Interactions · 17 May 2025 · 0 likes Nothing to add, except that this is the answer I would give if asked.
-
An emergency department visit, described afterwards Replied, post #21 · Safety › Adverse events · 16 May 2025 · 29 likes The useful distinction on emergency department visit is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
-
A certificate whose chromatogram axes do not match its stated method Replied, post #11 · Sourcing › Red flags · 16 May 2025 · 5 likes A certificate that reports a specification in the result column is a documentation defect, and it is a defect people should be able to recognise without it being called…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #79 · Sourcing › Independent verification · 11 May 2025 · 0 likes This follows post #76 rather than contradicting it. The version of Janoshik that circulates here is a simplification of a simplification. It is not wrong, but it has…
-
A well-designed study with a badly written abstract Replied, post #62 · Evidence › Study critique · 5 May 2025 · 20 likes Everything in post #61 holds. The case it does not cover is the one I have. Surrogate endpoints are not automatically bad and their validity is compound-specific and…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #26 · Compounds › Retatrutide · 21 Apr 2025 · 2 likes On Retatrutide mass and identity the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
-
A claim built entirely on a subgroup analysis Started this topic · Evidence › Study critique · 20 Apr 2025 · 26 likes A claim built entirely on a subgroup analysis Writing it up because I had to work it out twice and would rather nobody else did. I would like to disagree carefully with…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #18 · Devices › Pens & autoinjectors · 14 Apr 2025 · 0 likes Thank you — that answers what I came here to find out.
-
Requesting a page: what makes a good request Replied, post #36 · Documentation › Wiki requests · 27 Mar 2025 · 5 likes Everything in post #35 holds. The case it does not cover is the one I have. Scope creep: if you think a page is attempting too much and should be split into multiple…
-
Requesting a page: what makes a good request Replied, post #21 · Documentation › Wiki requests · 12 Mar 2025 · 12 likes A page that would need to be rewritten every quarter is usually better as a topic with a good marked solution.
-
Injection timing and sleep disruption — the long version Replied, post #2 · Wellbeing › Sleep · 9 Mar 2025 · 19 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #21 · Compounds › Tirzepatide · 5 Mar 2025 · 22 likes Worth separating two things that post #19 runs together. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #16 · Analytics › COA interpretation · 21 Feb 2025 · 2 likes The most useful reply I ever got about Counter-ion form was a request to state my units. It sounds like pedantry and it has saved me twice.
-
When a preprint is the best available evidence and we say so — a second dataset Replied, post #14 · Evidence › Preprints · 21 Feb 2025 · 24 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. The part I am sure of…
-
Requesting a page: what makes a good request Started this topic · Documentation › Wiki requests · 13 Feb 2025 · 46 likes Requesting a page: what makes a good request Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #49 · Clinical › Bloodwork · 8 Feb 2025 · 1 like Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Second pass at: Regression to the mean in progress reports Replied, post #37 · Research Methods › Statistics · 27 Jan 2025 · 25 likes Confirming post #36 from a second method, which matters more than confirming it from a second person. On Regression, I would rather understate and be corrected upward…
-
Review: a draft on reconstitution arithmetic, with objections Started this topic · Documentation › Doc review · 22 Jan 2025 · 17 likes Review: a draft on reconstitution arithmetic, with objections Writing it up because I had to work it out twice and would rather nobody else did. Proposing that draft on…
-
[2026 update] New subcategory: rationale and scope Replied, post #132 · Meta › Announcements · 8 Jan 2025 · 1 like The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists. Worth saying I have…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #18 · Practice › Reconstitution · 5 Jan 2025 · 0 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #118 · Compounds › Tirzepatide · 30 Dec 2024 · 3 likes Post #117 is right about the mechanism and I think understates the practical bit. On storage: published stability data covers the licensed formulation at its licensed…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #5 · Compounds › Secretagogues & GH axis · 26 Dec 2024 · 3 likes Answering the well-designed human trial question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #49 · Compounds › Oral incretins · 26 Dec 2024 · 0 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Transporting a vial for a weekend away Replied, post #28 · Practice › Storage & stability · 3 Nov 2024 · 4 likes If someone has run transporting a vial properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #62 · Analytics › Method validation · 30 Oct 2024 · 0 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Irish differences from the UK position Replied, post #64 · Regional › UK & Ireland · 29 Oct 2024 · 12 likes Members outside these two jurisdictions reading this thread should note that none of it transfers, including the parts that sound general.
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #18 · Pharmacology › Formulation chemistry · 25 Oct 2024 · 0 likes Practical answer on Buffers, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #80 · Practice › Dosing & titration · 10 Oct 2024 · 0 likes Coming back to post #77, because the follow-up matters more than the original answer. The four-week step is a trial convention, not a pharmacological constant. It is…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #23 · Compounds › Semaglutide · 10 Oct 2024 · 1 like Building on post #21 rather than restating it. Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #123 · Nutrition & Training › Hydration & electrolytes · 29 Sep 2024 · 0 likes Magnesium supplementation is widely recommended in this space with very little supporting evidence for the indications it is recommended for. It is the sort of thing…
-
Guidelines revision: what changed and why Replied, post #126 · Meta › Announcements · 28 Jul 2024 · 0 likes Small correction to my own earlier position on guidelines revision. I had the units the wrong way round, which changes the conclusion by an order of magnitude and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #105 · Compounds › Retatrutide · 23 Jul 2024 · 24 likes How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect and is tolerable enough to justify large trials. It does…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #20 · Practice › Dosing & titration · 7 Jul 2024 · 19 likes Post #17 answers the question as asked. The question underneath it is different. The four-week escalation interval is a convention from the pivotal trials, not a…
-
Spreadsheets: an appreciation Replied, post #27 · Lounge › Off topic · 9 Jun 2024 · 19 likes Adding what did not work for me on spreadsheets, since the failures never get written up and they are half the useful information.